HEALTH SCIENCE CENTER SEEKS PARTICIPANTS FOR EPILEPSY STUDY


Share this story:

FORT WORTH – Texas â?? A new medication is being studied at the UNT Health Science Center in the search for a more effective antiepileptic drug without as many side effects. Researchers are seeking additional medications so patients will have more options to choose from in their therapy.

The health science center is seeking males and females over the age of 12 with incompletely controlled epilepsy on at least one antiepileptic drug already. According to Dr. William McIntosh, chief of neurology at the UNT Health Science Center and the primary investigator in the study, the health science center is one of 80 sites in the United States and Canada seeking a total of 400 patients to enroll in the study. The health science center will seek participants to monitor on the new medication throughout the year.

Researchers hope the use of this study medication will prevent the number of seizures in patients. Most of these antiepileptic medications are not effective until they reach a certain level in the body, and that level has to be maintained. The goal is to keep the blood level high enough to prevent seizures, but not so high that it causes excessive sleepiness or other unpleasant side effects.

Previously over a dozen drugs, the oldest dating back to 1912, have been available for those with epilepsy. The most commonly prescribed drug still used today was developed in the 1950s.

According to the Centers for Disease Control, nearly 1.4 million Americans have epilepsy, with the majority of these Americans under age 45. Epilepsy is a neurological condition that from time to time produces brief disturbances in the normal electrical functions of the brain. Normal brain function is made possible by millions of tiny electrical charges passing between nerve cells in the brain and to all parts of the body. When someone has epilepsy, this normal pattern may be interrupted by irregular bursts of electrical energy (called epileptic seizures) that are much more intense than usual. They may affect a person’s consciousness, bodily movements or sensations for a short time.

In about seven out of ten people with epilepsy, no cause can be found. Among the rest, the cause may be any one of a number of things that can make a difference in the way the brain works, including head injuries, brain tumors, genetic conditions, problems in development of the brain before birth, and infections like meningitis or encephalitis.

All study-related medication, tests and exams will be provided free of charge. In many cases, volunteers are compensated for their time and travel expenses. Those interested can discuss clinical research participation with their doctor and call the Office of Clinical Trials at (817) 735-0256.

Share this story:

student standing by window

A sense of service and a desire to help

By Giovanny Destin, TCOM student   The challenges many of my students faced were etched on their faces when they arrived at Polytechnic High School each morning. Some were tired from working a job late in the evening to help support their families. Some showed stress from problems at h...Read more

Dec 12, 2017

Teamwork that produces better research

By Jan Jarvis   A new agreement between UNT Health Science Center and JPS Health Network is expected to open the door to new discoveries and give Tarrant County patients greater access to cutting-edge research and ultimately new treatments. This approach streamlines the process and mak...Read more

Dec 6, 2017

‘Don’t tell them that they can’t’

By Alex Branch Londyn Miner can pinpoint the moment that started her path to UNT Health Science Center. It was seven years ago in her Granbury living room, as she tearfully explained her 15-month-old son’s devastating prognosis to a physical therapist. An MRI had revealed that Orion...Read more

Dec 5, 2017

Taking aim at metastatic prostate cancer

By Jan Jarvis When prostate cancer spreads to the bone it can be challenging to treat and often results in pain, fractures and limited survival. But an approach that delivers chemotherapy directly to the cancerous bone lesions shows promise as a new treatment that reduces tumor size and re...Read more

Dec 4, 2017